Showing results (1581-1590 of 1,660) with videos related to

Sort By:
Pageof 166
Journal of the American Heart Association|July 12, 2021
Caregiver Health-Related Quality of Life, Burden, and Patient Outcomes in Ambulatory Advanced Heart Failure: A Report From REVIVALNisha A Gilotra, Salpy V Pamboukian, Maria Mountis, et al.
International Journal of Radiation Oncology, Biology, Physics|February 3, 2023
Neighborhood Deprivation and Rurality Associated With Patient-Reported Outcomes and Survival in Men With Prostate Cancer in NRG Oncology RTOG 0415Jinbing Bai, Stephanie L Pugh, Ronald Eldridge, et al.
The American Journal of Surgical Pathology|January 16, 2022
HPV51-associated Leiomyosarcoma: A Novel Class of TP53/RB1-Wildtype Tumor With Predilection for the Female Lower Reproductive TractErik A Williams, Meagan Montesion, Vadim Lincoln, et al.
The New England Journal of Medicine|January 10, 2024
Efficacy and Safety of Acoramidis in Transthyretin Amyloid CardiomyopathyJulian D Gillmore, Daniel P Judge, Francesco Cappelli, et al.
Diabetes/Metabolism Research and Reviews|May 17, 2020
The effects of canagliflozin compared to sitagliptin on cardiorespiratory fitness in type 2 diabetes mellitus and heart failure with reduced ejection fraction: The CANA-HF studySalvatore Carbone, Hayley E Billingsley, Justin M Canada, et al.
Cureus|February 5, 2024
Surgical Management of Congenital Pulmonary Airway Malformations (CPAM) in an Infant and a Toddler: Case Report Depicting Two Distinct Surgical Techniques With Successful OutcomesVishal V Bhende, Tanishq S Sharma, Mathangi Krishnakumar, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 25, 2019
Tolerance doses for late adverse events after hypofractionated radiotherapy for prostate cancer on trial NRG Oncology/RTOG 0415Maria Thor, Joseph O Deasy, Rebecca Paulus, et al.
Nature Cell Biology|January 22, 2019
An IRAK1-PIN1 signalling axis drives intrinsic tumour resistance to radiation therapyPeter H Liu, Richa B Shah, Yuanyuan Li, et al.
European Urology Oncology|July 17, 2025
Transcriptomic Analysis of Localized High-risk Prostate Cancer Improves Prognostication and Identifies Benefit from Adding Docetaxel to Definitive Radiotherapy with Androgen Suppression in the NRG Oncology/RTOG 0521 Phase 3 TrialRyan M Phillips, James A Proudfoot, Elai Davicioni, et al.
JCO Clinical Cancer Informatics|July 1, 2022
Methodological Comparison of Mapping the Expanded Prostate Cancer Index Composite to EuroQoL-5D-3L Using Cross-Sectional and Longitudinal Data: Secondary Analysis of NRG/RTOG 0415Rahul Khairnar, Lyudmila DeMora, Howard M Sandler, et al.
Pageof 166